The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
J Neuropsychiatry Clin Neurosci 18:217-225, May 2006
doi: 10.1176/appi.neuropsych.18.2.217
© 2006 American Neuropsychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Gualtieri, C. T.
* Articles by Benedict, K. B.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Gualtieri, C. T.
* Articles by Benedict, K. B.
Related Collections
* Depression
* Cognition

Clinical and Research Reports

Neurocognition in Depression: Patients on and Off Medication Versus Healthy Comparison Subjects

C. Thomas Gualtieri, M.D., Lynda G. Johnson, Ph.D. and Kenneth B. Benedict, M.D.

Received November 7, 2004; revised June 22, 2005; accepted June 27, 2005. From North Carolina Neuropsychiatry Clinics, Chapel Hill, North Carolina; and North Carolina Neuropsychology Clinics, Chapel Hill, North Carolina. Address correspondence to Dr. Gualtieri, NC Neuropsychiatry Clinics, 400 Franklin Sq., 1829 East Franklin St., Chapel Hill, NC 27514; tg{at}ncneuropsych.com (E-mail).

ABSTRACT

Patients with depression have neuropsychological deficits in attention, memory, psychomotor speed, processing speed, and executive function. It is not clear, however, whether neurocognition in depression is impaired in a global or nonspecific way or if specific cognitive domains are selectively impaired. This naturalistic cross-sectional study employed a computerized neurocognitive screening battery to evaluate 38 depressed, drug-free patients, compared to 31 patients who responded to antidepressant monotherapy and to 69 healthy comparison subjects. There was evidence for global neuropsychological impairment in untreated depressed patients. In patients who had been successfully treated, performance was improved but not normalized. There was also evidence for specific depression-related deficits in executive function and processing speed but not in memory, psychomotor speed, or reaction time. Although depressed patients have global neurocognitive impairments, deficits in certain cognitive domains are more important than in others. In particular, impairments are noted in tests of executive control and in tests that demand effortful attention. Information processing speed is also impaired but not reaction time. Computerized testing in the clinic setting demonstrates a range of neurocognitive problems in patients with depression. These problems may have a bearing on treatment and outcome.







Get information about faster international access.

Privacy Policy

Copyright © 2006 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org